文献速递神经肌肉病神经免疫

胸腺切除术式对重症肌无力完全稳定缓解率的影响:一项Meta分析

Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis.
PubMed 文献 · Neurology · 2021-05-04

结果显示,扩大胸腔镜与扩大胸骨切开等术式在3年及9年随访时缓解率相当,仅10年时基本颈径路与扩大胸骨切开术存在显著差异。

要点

  • 扩大胸腔镜与扩大胸骨切开术的完全稳定缓解率在3年及9年随访时无显著差异。
  • 仅10年随访时基本颈径路(非提胸骨)与扩大胸骨切开术的缓解率有显著差异。
  • 扩大微创术式在经验丰富的外科医生手中可获得与扩大胸骨切开术相当的缓解率。

核心结论

  • 不同胸腺切除术式仅在长期随访时发现完全稳定缓解率存在显著差异,且仅见于最激进与最保守术式之间。
  • 扩大微创术式的完全稳定缓解率与扩大胸骨切开术相当,适合有经验的外科医生实施。

研究设计与样本

  • 对提供胸腺切除术式比较数据、报告完全稳定缓解率且平均随访至少3年的研究进行Meta分析。

主要发现

  • 3年时,扩大胸腔镜与基本胸骨切开术的完全稳定缓解率相似(RR 1.00,p=1.00,95%CI 0.39-2.58)。
  • 3年时,扩大胸腔镜与扩大胸骨切开术的完全稳定缓解率相似(RR 0.96,p=0.74,95%CI 0.72-1.27)。
  • 3年时,扩大胸骨切开术与颈-剑突联合入路的完全稳定缓解率相似(RR 1.08,p=0.62,95%CI 0.8-1.44)。
  • 随访至9年,扩大胸腔镜与扩大胸骨切开术的完全稳定缓解率仍统计学等效(RR 1.51,p=0.05,95%CI 0.99-2.30)。
  • 10年时,基本颈径路(非提胸骨)与扩大胸骨切开术的完全稳定缓解率有显著差异(RR 0.4,p=0.01,95%CI 0.2-0.8)。

临床怎么用

  • 在经验丰富的外科医生手中,扩大微创胸腺切除术可作为扩大胸骨切开术的合适替代。
  • 基本颈径路(非提胸骨)因长期缓解率较低,现已弃用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine whether the available operative techniques for thymectomy in myasthenia gravis (MG) confer variable chances for achieving complete stable remission (CSR), we performed a meta-analysis of comparative studies of surgical approaches to thymectomy. METHODS: Meta-analysis was done of all studies providing comparative data on thymectomy approaches, with CSR reported and minimum 3-year mean follow-up. RESULTS: Twelve cohort studies and 1 randomized clinical trial, containing 1,598 patients, met entry criteria. At 3 years, CSR from MG was similar after video-assisted thoracoscopic (VATS) extended vs both basic (relative risk [RR] 1.00, p = 1.00, 95% confidence interval [CI] 0.39-2.58) and extended (RR 0.96, p = 0.74, 95% CI 0.72-1.27) transsternal approaches. CSR at 3 years was also similar after extended transsternal vs combined transcervical-subxiphoid (RR 1.08, p = 0.62, 95% CI 0.8-1.44) approaches. VATS extended approaches remained statistically equivalent to extended transsternal approaches through 9 years of follow-up (RR 1.51, p = 0.05, 95% CI 0.99-2.30). The only significant difference in CSR rate between a traditional open and a minimally invasive approach was seen at 10 years when the now-abandoned basic (non-sternum-lifting) transcervical approach was compared to the extended transsternal approach (RR 0.4, p = 0.01, 95% CI 0.2-0.8). CONCLUSIONS: A significant difference in the rate of CSR among various surgical approaches for thymectomy in MG was identified only at long-term follow-up and only between what might be considered the most aggressive approach (extended transsternal thymectomy) and the least aggressive approach (basic transcervical thymectomy). Extended minimally invasive approaches appear to have CSR rates equivalent to those of extended transsternal approaches and are therefore appropriate in the hands of experienced surgeons.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Solis-Pazmino P, Baiu I, Lincango-Naranjo E, et al. Impact of the Surgical Approach to Thymectomy Upon Complete Stable Remission Rates in Myasthenia Gravis: A Meta-analysis. Neurology. 2021. PMID: 33947783. doi:10.1212/WNL.0000000000012153

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。